Skip to content

Protocadherin alpha-9 (PCDHA9)

Homo sapiens — UniProt Q9Y5H5

Gene: PCDHA9Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Protocadherin alpha-9 (PCDHA9) is a protein from Homo sapiens identified by UniProt accession Q9Y5H5, 950 residues long. MolForge cross-references it against 0 known binders and 24 disease associations.

  • UniProt accession: Q9Y5H5; gene symbol PCDHA9.
  • Organism: Homo sapiens.
  • Length: 950 amino acids.
  • Top disease associations (Open Targets): neurodegenerative disease, forced expiratory volume and Thrombocytosis.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameProtocadherin alpha-9
UniProt accessionQ9Y5H5
GenePCDHA9
OrganismHomo sapiens
Length950 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (24)

Diseases linked to this target (Open Targets).

  • neurodegenerative disease · score 0.33
  • forced expiratory volume · score 0.14
  • Thrombocytosis · score 0.12
  • prostate carcinoma · score 0.11
  • prostate cancer · score 0.11
  • Familial prostate cancer · score 0.11
  • Hirschsprung disease · score 0.11
  • vital capacity · score 0.07
  • granulocyte count · score 0.06
  • Abnormality of refraction · score 0.06

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9Y5H5-F1alphafoldPREDICTED73.22—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9Y5H5.

Amino-acid sequence (950 residues)

MLYSSRGDPE GQPLLLSLLI LAMWVVGSGQ LHYSVPEEAE HGTFVGRIAQ DLGLELAELV PRLFQLDSKG RGDLLEVNLQ NGILFVNSRI DREELCGRSA ECSIHLEVIV DRPLQVFHVD VEVKDINDNP PVFPATQKNL FIAESRPLDS RFPLEGASDA DIGENALLTY RLSPNEYFFL DVPTSNQQVK PLGLVLRKLL DREETPELHL LLTATDGGKP ELTGTVQLLI TVLDNNDNAP VFDRTLYTVK LPENVSIGTL VIHPNASDLD EGLNGDIIYS FSSDVSPDIK SKFHMDPLSG AITVIGHMDF EESRAHKIPV EAVDKGFPPL AGHCTLLVEV VDVNDNAPQL TIKTLSVPVK EDAQLGTVIA LISVIDLDAD ANGQVTCSLT PHVPFKLVST YKNYYSLVLD RALDRESVSA YELVVTARDG GSPSLWATAR VSVEVADVND NAPAFAQSEY TVFVKENNPP GCHIFTVSAR DADAQENALV SYSLVERRLG ERSLSSYVSV HAESGKVYAL QPLDHEELEL LQFQVSARDA GVPPLGSNVT LQVFVLDEND NAPALLTPRM RGTDGAVSEM VLRSVGAGVV VGKVRAVDAD SGYNAWLSYE LQPETASASI PFRVGLYTGE ISTTRALDET DAPRQRLLVL VKDHGEPALT ATATVLVSLV ESGQAPKSSS RASVGATGPE VTLVDVNVYL IIAICAVSSL LVLTLLLYTV LRCSAMPTEG ECAPGKPTLV CSSAVGSWSY SQQRRQRVCS GEGKQKTDLM AFSPGLSPCA GSTERTGEPS ASSDSTGKPR QPNPDWRYSA SLRAGMHSSV HLEEAGILRA GPGGPDQQWP TVSSATPEPE AGEVSPPVGA GVNSNSWTFK YGPGNPKQSG PGELPDKFII PGSPAIISIR QEPTNSQIDK SDFITFGKKE ETKKKKKKKK GNKTQEKKEK GNSTTDNSDQ

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with PCDHA9?

The strongest Open Targets associations for PCDHA9 are neurodegenerative disease, forced expiratory volume, Thrombocytosis, prostate carcinoma and prostate cancer.

How long is the PCDHA9 protein?

The Homo sapiens PCDHA9 protein (UniProt Q9Y5H5) is 950 amino acids long.

Browse: Targets: P · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Protocadherin alpha-9 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9Y5H5
GenePCDHA9
OrganismHomo sapiens
Length950
Binders0
Diseases24
View on UniProt